NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/25/2023
Back to search
Official data from USPTO
GLUTRAPEPTIDE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
GLUTRAPEPTIDE
ST13
US500000079047439Class
3
Filing
79047439
Registration
3527788
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
11/25/2023
Trademark type
Word
Nice classes
3
Filing date
07/31/2007
Registration date
11/04/2008
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/07/2018
Last transaction
11/07/2018
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
09
Owner location
MONACO, MC
Examiner
STRUCK, ROBERT
Law office
L90
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
EXSYMOL, Société Anonyme Monégasque
Representatives
Edward A. Houlehan Wolfe & Houlehan PLLC
Technical classification
Nice Classes
Class 3
Vienna Codes
No Vienna codes available.
Goods and services
Class 3
Active chemical sold as an ingredient of cosmetics
Publications
History of USPTO decisions and trademark events.
33 publications found
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
11/07/2018
71AG
REGISTERED-SEC.71 ACCEPTED
11/07/2018
ES71
TEAS SECTION 71 RECEIVED
11/01/2018
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11/04/2017
RNWL
INTERNATIONAL REGISTRATION RENEWED
10/05/2017
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/26/2014
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/21/2014
71AG
REGISTERED-SEC.71 ACCEPTED
10/21/2014
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2014
ES71
TEAS SECTION 71 RECEIVED
10/10/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/31/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/18/2009
FIMP
FINAL DISPOSITION PROCESSED
02/18/2009
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/04/2009
R.PR
REGISTERED-PRINCIPAL REGISTER
11/04/2008
PUBO
PUBLISHED FOR OPPOSITION
08/19/2008
NPUB
NOTICE OF PUBLICATION
07/30/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
07/16/2008
ALIE
ASSIGNED TO LIE
07/16/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2008
ACEC
AMENDMENT FROM APPLICANT ENTERED
07/01/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/01/2008
ALIE
ASSIGNED TO LIE
07/01/2008
FAXX
FAX RECEIVED
06/30/2008
RFNT
REFUSAL PROCESSED BY IB
02/08/2008
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
01/11/2008
RFRR
REFUSAL PROCESSED BY MPU
01/11/2008
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
01/11/2008
CNRT
NON-FINAL ACTION WRITTEN
01/10/2008
DOCK
ASSIGNED TO EXAMINER
01/04/2008
NWAP
NEW APPLICATION ENTERED
01/04/2008
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/03/2008
Continuous trademark protection
Get notified about every new filing that threatens GLUTRAPEPTIDE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.